v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock and Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   47,823    
Beginning balance at Dec. 31, 2024 $ 2,951,125 $ 706,817 $ 2,292,819 $ (48,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 449,827   449,827  
Other comprehensive income 25,808     25,808
Dividends and dividend equivalents declared (227,725)   (227,725)  
Common stock issued (in shares)   88    
Common stock issued $ 9,220 $ 9,220    
Repurchases of common stock (in shares) (6,000) (6)    
Repurchases of common stock $ (4,501) $ (4,501)    
Stock-based compensation expense 173,587 $ 173,587    
Ending balance (in shares) at Sep. 30, 2025   47,905    
Ending balance at Sep. 30, 2025 3,377,341 $ 885,123 2,514,921 (22,703)
Beginning balance (in shares) at Jun. 30, 2025   47,892    
Beginning balance at Jun. 30, 2025 3,209,970 $ 822,582 2,411,079 (23,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 179,766   179,766  
Other comprehensive income 988     988
Dividends and dividend equivalents declared (75,924)   (75,924)  
Common stock issued (in shares)   15    
Common stock issued $ 3,885 $ 3,885    
Repurchases of common stock (in shares) (2,000) (2)    
Repurchases of common stock $ (2,017) $ (2,017)    
Stock-based compensation expense 60,673 $ 60,673    
Ending balance (in shares) at Sep. 30, 2025   47,905    
Ending balance at Sep. 30, 2025 $ 3,377,341 $ 885,123 2,514,921 (22,703)
Beginning balance (in shares) at Dec. 31, 2025 48,709 48,709    
Beginning balance at Dec. 31, 2025 $ 3,531,497 $ 936,998 2,609,651 (15,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 721,591   721,591  
Other comprehensive income 24,405     24,405
Dividends and dividend equivalents declared (297,184)   (297,184)  
Common stock issued (in shares)   448    
Common stock issued $ 10,656 $ 10,656    
Repurchases of common stock (in shares) (365) (365)    
Repurchases of common stock $ (457,481) $ (457,481)    
Stock-based compensation expense $ 200,256 $ 200,256    
Ending balance (in shares) at Sep. 30, 2026 48,792 48,792    
Ending balance at Sep. 30, 2026 $ 3,733,740 $ 690,429 3,034,058 9,253
Beginning balance (in shares) at Jun. 30, 2026   49,142    
Beginning balance at Jun. 30, 2026 3,895,424 $ 1,033,062 2,861,853 509
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 271,067   271,067  
Other comprehensive income 8,744     8,744
Dividends and dividend equivalents declared (98,862)   (98,862)  
Common stock issued (in shares)   12    
Common stock issued $ 4,825 $ 4,825    
Repurchases of common stock (in shares) (362) (362)    
Repurchases of common stock $ (453,432) $ (453,432)    
Stock-based compensation expense $ 105,974 $ 105,974    
Ending balance (in shares) at Sep. 30, 2026 48,792 48,792    
Ending balance at Sep. 30, 2026 $ 3,733,740 $ 690,429 $ 3,034,058 $ 9,253